Results 131 to 140 of about 1,428 (187)

[Therapeutic drug option for dyslipaemia]. [PDF]

open access: yesAten Primaria, 2010
Maiques Galan A, Brotons Cuixart C.
europepmc   +1 more source

Rhabdomyolysis as a manifestation of clomipramine poisoning. [PDF]

open access: yesSao Paulo Med J, 2013
Santana NO, Góis AF.
europepmc   +1 more source

Rabdomiolisis de esfuerzo

open access: yes, 2012
Rodríguez Sánchez, L   +3 more
openaire   +1 more source

Rabdomiolisi traumatiche e non traumatiche

open access: yesEMC - Anestesia-Rianimazione
P. Goudy, T. Geeraerts
openaire   +1 more source

[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?] [PDF]

open access: yesSemergen, 2020
Pallarés Carratalá V   +4 more
europepmc   +1 more source

Prevalence of systemic complications of COVID-19 in critically ill patients: systematic review with meta-analysis. [PDF]

open access: yesRev Lat Am Enfermagem
Sawada NO   +8 more
europepmc   +1 more source

[Rhabdomyolysis induced by cerivastatin]. [PDF]

open access: yesAten Primaria, 2001
Hernanz Hernanz P   +3 more
europepmc   +1 more source

[Cerivastatin and gemfibrozil: a dangerous combination]. [PDF]

open access: yesAten Primaria, 2001
Tormo Molina J   +2 more
europepmc   +1 more source

[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram]. [PDF]

open access: yesAten Primaria, 2004
Vich Pérez P   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy